{"id":40408,"date":"2021-11-01T17:01:53","date_gmt":"2021-11-01T21:01:53","guid":{"rendered":"https:\/\/www.arisglobal.com\/?p=40408"},"modified":"2021-11-01T17:01:53","modified_gmt":"2021-11-01T21:01:53","slug":"suzhou-ribo-life-science-adopts-lifesphere-multivigilance","status":"publish","type":"post","link":"https:\/\/www.arisglobal.com\/media\/press-release\/suzhou-ribo-life-science-adopts-lifesphere-multivigilance\/","title":{"rendered":"Suzhou Ribo Life Science Co. Ltd. Adopts ArisGlobal\u2019s LifeSphere\u00ae MultiVigilance to Advance Data Management from Clinical Trials"},"content":{"rendered":"<p><em>Innovative R&amp;D company selects LifeSphere by ArisGlobal to further develop its safety capabilities <\/em><\/p>\n<p><strong>MIAMI <\/strong><strong>\u2013 <\/strong><strong>November 1, 2021 <\/strong><strong>\u2013 <\/strong><a href=\"https:\/\/arisglobal.com\/\">ArisGlobal<\/a>, the leading provider of life sciences software that automates core drug development with its end-to-end drug development technology platform LifeSphere<sup>\u00ae <\/sup>today announced its partnership with <a href=\"https:\/\/www.ribolia.com\/en\">Suzhou Ribo Life Science Co., Ltd.<\/a>, an innovative R&amp;D company devoted to the development of nucleic acid drugs and related products based on the RNA interference (RNAi) technology. Ribo will leverage ArisGlobal\u2019s LifeSphere Multivigilance in English and Chinese to manage safety data and meet regulatory requirements as products move towards clinical trials.<\/p>\n<p>\u201cClinical trials continue to generate copious amounts of safety data for new products, and purposeful insights are critical for safely bringing products to market,\u201d said Beena Wood, ArisGlobal\u2019s Vice President of Safety. \u201cAs Ribo works with a multitude of R&amp;D pipelines of oligonucleotide therapeutics, LifeSphere Multivigilance can provide data models to connect siloed data sets across global markets and combine them into valuable data fabric.\u201d<\/p>\n<p>LifeSphere Multivigilance is a program within LifeSphere\u2019s Safety product line, and is an end-to-end, automated system that helps pharmacovigilance teams save time and effort, ensure future-proof compliance, and keep global teams aligned. The platform uses AI to bring efficiency to workflows and offers 100% compliance with present and future regulatory requirements.<\/p>\n<p>\u201cAs Ribo continues to bring innovative products into the clinical trial phase at a global scale, we needed to select an equally innovative safety system with stable performance and strong capabilities to manage data,\u201d said Jing Fu, Vice President at Ribo. \u201cWe have confidence in ArisGlobal products, and I believe that our partnership will propel us forward as we bring more products to the clinical trial stage in China and internationally.\u201d<\/p>\n<p>This news comes after ArisGlobal presented its signature conference Breakthrough2021 with key discussions around safety, automation &amp; AI adoption, and data, along with the 2021 State of the Industry report for life sciences R&amp;D technology.<\/p>\n<p>To learn more about ArisGlobal please visit, <a href=\"https:\/\/www.arisglobal.com\/\">www.arisglobal.com<\/a><\/p>\n<style>\nsup {<br \/>\nbottom: 0 !important;<br \/>\n}<br \/>\n<\/style>\n","protected":false},"excerpt":{"rendered":"<p>Innovative R&amp;D company selects LifeSphere by ArisGlobal to further develop [&hellip;]<\/p>\n","protected":false},"author":27,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[65],"tags":[],"class_list":["post-40408","post","type-post","status-publish","format-standard","hentry","category-press-release"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.4 (Yoast SEO v23.9) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Suzhou Ribo Life Science Co. Ltd. Adopts ArisGlobal\u2019s LifeSphere\u00ae MultiVigilance to Advance Data Management from Clinical Trials | ArisGlobal<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.arisglobal.com\/media\/press-release\/suzhou-ribo-life-science-adopts-lifesphere-multivigilance\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Suzhou Ribo Life Science Co. Ltd. Adopts ArisGlobal\u2019s LifeSphere\u00ae MultiVigilance to Advance Data Management from Clinical Trials\" \/>\n<meta property=\"og:description\" content=\"Innovative R&amp;D company selects LifeSphere by ArisGlobal to further develop [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.arisglobal.com\/media\/press-release\/suzhou-ribo-life-science-adopts-lifesphere-multivigilance\/\" \/>\n<meta property=\"og:site_name\" content=\"ArisGlobal\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/LifeSphereAG\/\" \/>\n<meta property=\"article:published_time\" content=\"2021-11-01T21:01:53+00:00\" \/>\n<meta name=\"author\" content=\"Mladen Prenc\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Mladen Prenc\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.arisglobal.com\/media\/press-release\/suzhou-ribo-life-science-adopts-lifesphere-multivigilance\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.arisglobal.com\/media\/press-release\/suzhou-ribo-life-science-adopts-lifesphere-multivigilance\/\"},\"author\":{\"name\":\"Mladen Prenc\",\"@id\":\"https:\/\/www.arisglobal.com\/#\/schema\/person\/bb2c7aafe44a090bcd667448651eb974\"},\"headline\":\"Suzhou Ribo Life Science Co. Ltd. Adopts ArisGlobal\u2019s LifeSphere\u00ae MultiVigilance to Advance Data Management from Clinical Trials\",\"datePublished\":\"2021-11-01T21:01:53+00:00\",\"dateModified\":\"2021-11-01T21:01:53+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.arisglobal.com\/media\/press-release\/suzhou-ribo-life-science-adopts-lifesphere-multivigilance\/\"},\"wordCount\":352,\"commentCount\":1,\"publisher\":{\"@id\":\"https:\/\/www.arisglobal.com\/#organization\"},\"articleSection\":[\"Press Releases\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/www.arisglobal.com\/media\/press-release\/suzhou-ribo-life-science-adopts-lifesphere-multivigilance\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.arisglobal.com\/media\/press-release\/suzhou-ribo-life-science-adopts-lifesphere-multivigilance\/\",\"url\":\"https:\/\/www.arisglobal.com\/media\/press-release\/suzhou-ribo-life-science-adopts-lifesphere-multivigilance\/\",\"name\":\"Suzhou Ribo Life Science Co. Ltd. Adopts ArisGlobal\u2019s LifeSphere\u00ae MultiVigilance to Advance Data Management from Clinical Trials | ArisGlobal\",\"isPartOf\":{\"@id\":\"https:\/\/www.arisglobal.com\/#website\"},\"datePublished\":\"2021-11-01T21:01:53+00:00\",\"dateModified\":\"2021-11-01T21:01:53+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.arisglobal.com\/media\/press-release\/suzhou-ribo-life-science-adopts-lifesphere-multivigilance\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.arisglobal.com\/media\/press-release\/suzhou-ribo-life-science-adopts-lifesphere-multivigilance\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.arisglobal.com\/media\/press-release\/suzhou-ribo-life-science-adopts-lifesphere-multivigilance\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.arisglobal.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Suzhou Ribo Life Science Co. Ltd. Adopts ArisGlobal\u2019s LifeSphere\u00ae MultiVigilance to Advance Data Management from Clinical Trials\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.arisglobal.com\/#website\",\"url\":\"https:\/\/www.arisglobal.com\/\",\"name\":\"ArisGlobal\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.arisglobal.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.arisglobal.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.arisglobal.com\/#organization\",\"name\":\"LifeSphere\",\"url\":\"https:\/\/www.arisglobal.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.arisglobal.com\/#\/schema\/logo\/image\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"LifeSphere\"},\"image\":{\"@id\":\"https:\/\/www.arisglobal.com\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/LifeSphereAG\/\",\"https:\/\/www.linkedin.com\/products\/aris-global-lifesphere\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.arisglobal.com\/#\/schema\/person\/bb2c7aafe44a090bcd667448651eb974\",\"name\":\"Mladen Prenc\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Suzhou Ribo Life Science Co. Ltd. Adopts ArisGlobal\u2019s LifeSphere\u00ae MultiVigilance to Advance Data Management from Clinical Trials | ArisGlobal","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.arisglobal.com\/media\/press-release\/suzhou-ribo-life-science-adopts-lifesphere-multivigilance\/","og_locale":"en_US","og_type":"article","og_title":"Suzhou Ribo Life Science Co. Ltd. Adopts ArisGlobal\u2019s LifeSphere\u00ae MultiVigilance to Advance Data Management from Clinical Trials","og_description":"Innovative R&amp;D company selects LifeSphere by ArisGlobal to further develop [&hellip;]","og_url":"https:\/\/www.arisglobal.com\/media\/press-release\/suzhou-ribo-life-science-adopts-lifesphere-multivigilance\/","og_site_name":"ArisGlobal","article_publisher":"https:\/\/www.facebook.com\/LifeSphereAG\/","article_published_time":"2021-11-01T21:01:53+00:00","author":"Mladen Prenc","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Mladen Prenc","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.arisglobal.com\/media\/press-release\/suzhou-ribo-life-science-adopts-lifesphere-multivigilance\/#article","isPartOf":{"@id":"https:\/\/www.arisglobal.com\/media\/press-release\/suzhou-ribo-life-science-adopts-lifesphere-multivigilance\/"},"author":{"name":"Mladen Prenc","@id":"https:\/\/www.arisglobal.com\/#\/schema\/person\/bb2c7aafe44a090bcd667448651eb974"},"headline":"Suzhou Ribo Life Science Co. Ltd. Adopts ArisGlobal\u2019s LifeSphere\u00ae MultiVigilance to Advance Data Management from Clinical Trials","datePublished":"2021-11-01T21:01:53+00:00","dateModified":"2021-11-01T21:01:53+00:00","mainEntityOfPage":{"@id":"https:\/\/www.arisglobal.com\/media\/press-release\/suzhou-ribo-life-science-adopts-lifesphere-multivigilance\/"},"wordCount":352,"commentCount":1,"publisher":{"@id":"https:\/\/www.arisglobal.com\/#organization"},"articleSection":["Press Releases"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.arisglobal.com\/media\/press-release\/suzhou-ribo-life-science-adopts-lifesphere-multivigilance\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.arisglobal.com\/media\/press-release\/suzhou-ribo-life-science-adopts-lifesphere-multivigilance\/","url":"https:\/\/www.arisglobal.com\/media\/press-release\/suzhou-ribo-life-science-adopts-lifesphere-multivigilance\/","name":"Suzhou Ribo Life Science Co. Ltd. Adopts ArisGlobal\u2019s LifeSphere\u00ae MultiVigilance to Advance Data Management from Clinical Trials | ArisGlobal","isPartOf":{"@id":"https:\/\/www.arisglobal.com\/#website"},"datePublished":"2021-11-01T21:01:53+00:00","dateModified":"2021-11-01T21:01:53+00:00","breadcrumb":{"@id":"https:\/\/www.arisglobal.com\/media\/press-release\/suzhou-ribo-life-science-adopts-lifesphere-multivigilance\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.arisglobal.com\/media\/press-release\/suzhou-ribo-life-science-adopts-lifesphere-multivigilance\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.arisglobal.com\/media\/press-release\/suzhou-ribo-life-science-adopts-lifesphere-multivigilance\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.arisglobal.com\/"},{"@type":"ListItem","position":2,"name":"Suzhou Ribo Life Science Co. Ltd. Adopts ArisGlobal\u2019s LifeSphere\u00ae MultiVigilance to Advance Data Management from Clinical Trials"}]},{"@type":"WebSite","@id":"https:\/\/www.arisglobal.com\/#website","url":"https:\/\/www.arisglobal.com\/","name":"ArisGlobal","description":"","publisher":{"@id":"https:\/\/www.arisglobal.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.arisglobal.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.arisglobal.com\/#organization","name":"LifeSphere","url":"https:\/\/www.arisglobal.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.arisglobal.com\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"LifeSphere"},"image":{"@id":"https:\/\/www.arisglobal.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/LifeSphereAG\/","https:\/\/www.linkedin.com\/products\/aris-global-lifesphere\/"]},{"@type":"Person","@id":"https:\/\/www.arisglobal.com\/#\/schema\/person\/bb2c7aafe44a090bcd667448651eb974","name":"Mladen Prenc"}]}},"_links":{"self":[{"href":"https:\/\/www.arisglobal.com\/wp-json\/wp\/v2\/posts\/40408"}],"collection":[{"href":"https:\/\/www.arisglobal.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.arisglobal.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.arisglobal.com\/wp-json\/wp\/v2\/users\/27"}],"replies":[{"embeddable":true,"href":"https:\/\/www.arisglobal.com\/wp-json\/wp\/v2\/comments?post=40408"}],"version-history":[{"count":0,"href":"https:\/\/www.arisglobal.com\/wp-json\/wp\/v2\/posts\/40408\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.arisglobal.com\/wp-json\/wp\/v2\/media?parent=40408"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.arisglobal.com\/wp-json\/wp\/v2\/categories?post=40408"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.arisglobal.com\/wp-json\/wp\/v2\/tags?post=40408"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}